The Laramar Group Expanding into Medical Office Sector

Ben Slad, senior vice president of Investments with Laramar Group.

The Laramar Group, a leading national real estate investment and property management company with offices in Denver and Chicago, is actively investing for its Laramar Medical Properties Fund I, a closed-end fund investing in medical office and life sciences properties.

Laramar Medical Properties plans to invest in targeted U.S. markets nationally. Laramar Medical Properties closed on three assets in 2021 and projects to acquire seven to 10 assets in total ranging in size from $10 million to $50 million.

“Laramar Medical Properties Fund I is focused on generating consistent distributable cash flow balanced with value-add upside that we believe will result in superior risk-adjusted returns,” said Ben Slad, senior vice president of Investments. “We see significant opportunity in the medical office and life sciences sectors given the strong demand drivers, demographic tailwinds and moderated supply.”

The fund is designed to maximize investment returns through the assembly of a strategic portfolio of properties that support value creation at both the asset and portfolio levels. The fund is focused on multi-tenant assets with health system, credit or dominant regional tenancy, favorable WALT, diversified medical uses, and assets that offer opportunities to enhance value through increased occupancy and building improvements.

The medical office sector has positive long-term demographics, including an aging population, rising national healthcare expenditures, and favorable supply/demand drivers. Population shifts, rising healthcare costs and an increased focus on patient convenience have moved medical care toward off-campus medical offices that are tied into community health systems and are considered a critical juncture in the healthcare delivery model.

Demand for medical office buildings currently outpaces supply and that trend is projected to continue due to demographic factors. There is also a growing demand for life sciences and biotech properties with a record level of venture capital and national fundraising occurring in that sector.

“We have a long-term view and plan to invest in this sector through a series of Funds over many years. With our attention to detail and entrepreneurial spirit, we can offer investors significant value and put capital to work in a thoughtful manner,” said Slad.

Related Posts

Scroll to Top